Europe votes in new anti-counterfeit law
February 21, 2011Manufacturing and Production EFPIA, counterfeits, supply chain
The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …
Four steps to turn around a flagging pharma brand
February 21, 2011Sales and Marketing MSI, branding, brands, marketing
The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …
Idea Pharma boosts UK and US teams
February 21, 2011Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing
Idea Pharma has made new appointments to its UK- and US-based teams
Astellas to commercialise new kidney cancer drug in Europe
February 21, 2011Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib
Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Matt de Gruchy to lead Ogilvy Healthworld UK
February 18, 2011Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications
Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …
Digital Pharma: Merck Serono sets up MS social network
February 18, 2011Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking
Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …
Merck Serono halts Movectro European licence application
February 18, 2011Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis
Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
Value-based pricing will not harm industry, says NICE chief
February 18, 2011Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing
NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …
AZ accepts $92.5m to settle respiratory dispute
February 18, 2011Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory
AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …
Trial failures threaten UK biotech
February 18, 2011Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Bennett appointed chairman of Monitor
February 18, 2011Sales and Marketing Monitor, NHS
Monitor, the body which will take on a powerful new role in regulating competition in the NHS, has a new …
Vidaza patient access scheme sways NICE
February 17, 2011Sales and Marketing Celgene, NICE, Vidaza
Celgene’s Vidaza has been recommended by NICE in final draft guidance issued today. Vidaza (azacitidine) is recommended as a treatment …
e-Therapeutics success in £17 million financing
February 17, 2011Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics
UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …
Pharma industry R&D pipelines
February 16, 2011Research and Development pipeline, pipelines
New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …
Lilly hails progress of new R&D approaches
February 16, 2011Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly
Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Companies join forces to promote AF awareness
February 16, 2011Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation
Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …
Sanofi seals Genzyme deal for $20 billion
February 16, 2011Research and Development, Sales and Marketing Genzyme, Sanofi
Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
Sefton takes over at Ketchum Pleon healthcare
February 16, 2011Medical Communications Ketchum Pleon, PR, appointment, medical communications, recruitment
Ketchum Pleon, the leading communications consultancy in the UK and Europe, has announced today that Amanda Sefton has been named …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
